Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Innovent Announces First Subject Dosed in Trial of Anti-IL-23 Monoclonal Antibody

americanpharmaceuticalreviewSeptember 02, 2020

Tag: Innovent Biologics , IL-23 , IBI112

PharmaSources Customer Service